CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleLevered free cash flow is $63.7M, above the global median of $16.24M
- FinancialsAltman Z-Score 2.59: grey zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
734.33MUSDvs all stocks (USD)
Revenue (TTM)
340.30MUSDvs all stocks (USD)
Profit Margin
-2.15%Beta
-0.5790xvs all stocks
52-Week Change
-17.52%vs all stocks
Market Capitalization
734.33MUSDvs all stocks (USD)
Enterprise Value
595.05MUSDvs all stocks (USD)
Forward P/E
18.38xPrice to Sales (TTM)
2.16xPrice to Book (MRQ)
2.98xEnterprise to Revenue
1.75xEnterprise to EBITDA
-109.12xGross Margin
76.42%Profit Margin
-2.15%Operating Margin
-12.96%Return on Assets (TTM)
-0.87%Return on Equity (TTM)
-2.25%Revenue (TTM)
340.30MUSDvs all stocks (USD)
Revenue per Share (TTM)
12.74USDUpdated Jul 19, 2026Quarterly Revenue Growth
-2.50%Gross Profit (TTM)
266.88MUSDvs all stocks (USD)
EBITDA (TTM)
7.48MUSDvs all stocks (USD)
Net Income (TTM)
-7.30MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-2.47%Operating Cash Flow (TTM)
105.79MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
63.70MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
342.39MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
71.06MUSDFY2025 · Dec 31, 2025Gross Profit
271.33MUSDFY2025 · Dec 31, 2025Operating Income
-841.00KUSDvs all stocks (USD)
Pre-tax Income
9.85MUSDFY2025 · Dec 31, 2025Income Tax Expense
6.27MUSDFY2025 · Dec 31, 2025Net Income
3.58MUSDFY2025 · Dec 31, 2025EBIT
-841.00KUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
7.48MUSDFY2025 · Dec 31, 2025Research & Development
61.08MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
207.18MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.1300USDFY2025 · Dec 31, 2025EPS (Diluted)
0.1200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
28.37MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
28.37MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
3.58MUSDFY2025 · Dec 31, 2025Operating Cash Flow
71.67MUSDFY2025 · Dec 31, 2025Free Cash Flow
51.37MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
186.61MUSDFY2025 · Dec 31, 2025Income Tax Paid
5.15MUSDFY2025 · Dec 31, 2025Interest Paid
247.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
3.58MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
8.32MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
3.15MUSDFY2025 · Dec 31, 2025Stock-based Compensation
44.14MUSDFY2025 · Dec 31, 2025Other Non-cash Items
182.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
10.24MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
355.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
1.71MUSDFY2025 · Dec 31, 2025Capital Expenditures
-20.29MUSDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-20.29MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-232.97MUSDFY2025 · Dec 31, 2025Other Financing Charges
-3.42MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-236.39MUSDFY2025 · Dec 31, 2025Shares Outstanding
23.51MSharesUpdated Jul 19, 2026Float Shares
7.19MSharesUpdated Jul 19, 2026Shares Short
3.05MSharesUpdated Jul 19, 2026Short Ratio
17.41daysvs all stocks
Short % of Shares Outstanding
28.75%vs all stocks
% Held by Insiders
52.34%vs all stocks
% Held by Institutions
50.91%vs all stocks
Total Cash (MRQ)
164.60MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
7.07USDUpdated Jul 19, 2026Total Debt (MRQ)
25.32MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1017xCurrent Ratio (MRQ)
1.80xBook Value per Share (MRQ)
10.59USDUpdated Jul 19, 2026Total Assets
525.91MUSDvs all stocks (USD)
Total Current Assets
407.93MUSDFY2025 · Dec 31, 2025Total Liabilities
238.26MUSDFY2025 · Dec 31, 2025Total Non-current Assets
117.99MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
30.50MUSDFY2025 · Dec 31, 2025Total Current Liabilities
207.76MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
186.61MUSDFY2025 · Dec 31, 2025Accounts Receivable
208.71MUSDFY2025 · Dec 31, 2025Accounts Payable
10.84MUSDFY2025 · Dec 31, 2025Deferred Revenue
2.94MUSDFY2025 · Dec 31, 2025Other Current Liabilities
66.77MUSDFY2025 · Dec 31, 2025Long-term Debt
25.50MUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-136.87MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
287.65MUSDvs all stocks (USD)
Treasury Stock
267.57MUSDFY2025 · Dec 31, 202552-Week Low
19.10USDUpdated Jul 19, 202652-Week High
41.14USDUpdated Jul 19, 202652-Week Change
-17.52%vs all stocks
Beta
-0.5790xvs all stocks
50-Day MA
32.80USDUpdated Jul 19, 2026200-Day MA
28.17USDUpdated Jul 19, 2026Avg 10-Day Volume
147.23KSharesUpdated Jul 19, 2026Avg 30-Day Volume
163.39KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-0.3300USDUpdated Jul 19, 2026Other Income / Expense
-93.00KUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
Total Revenue Growth With Buyback Amplification And Heavy SGA
Revenue is growing and buybacks shrink the share count, so per-share growth runs faster.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.76Profit Margin: -0.02
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.32Revenue Growth YoY: -0.03
Financial Health
Altman Z-Score 2.59: grey zoneSignificant
Altman Z-Score: 2.59
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Levered free cash flow is $63.7M, above the global median of $16.24MNotable
Levered free cash flow (USD): 63,695,124Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Auction Technology Group plc
Tier 1InterfaceRecurring-Revenue Lock-InFlowAttention
Truecaller AB
Tier 1InterfaceRecurring-Revenue Lock-InAttentionFlow
VTEX Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Viant Technology Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
SMS Co. Ltd.
Tier 1InterfaceRecurring-Revenue Lock-InSenseMakingFlow
Sabre Corporation
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
PagerDuty Inc.
Tier 1InterfaceRecurring-Revenue Lock-InSenseMakingFlow
MNTN, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InAttentionFlow
Talkspace Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
PubMatic Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Doximity Inc.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedTotal Revenue Growth With Buyback Amplification And Heavy SGA
Oddity Tech Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedTotal Revenue Growth With Buyback Amplification And Heavy SGA
Rumble Inc.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedTotal Revenue Growth With Buyback Amplification And Heavy SGA